OrganiGram Holdings Inc. (OGI) Cash Flow Statement

NASDAQ: OGIOperating cash, capex, free cash flow and buybacks.

Where OGI’s cash came from and went, FY2025

September 30, 2025 · Canadian dollars
Cash from operations
−C$7.6M
−296.0% vs FY2024
Capital expenditures
C$17.0M
9.2% of revenue
Free cash flow
−C$24.6M
−13.2% margin
Returned to shareholders
—
Change in cash
−C$49.0M
cash at year-end C$83.6M
Shares issued: C$41.2MShares issuedC$41.2MDrawn from cash: C$49.0MDrawn from cashC$49.0MInvestments (net), Currency & other: C$1.8MOther sourcesC$1.8MAcquisitions & other: C$65.5MAcquisitions & otherC$65.5M · 71%Capital expenditures: C$17.0MCapital expendituresC$17.0M · 19%Cash used in operations: C$7.6MCash used in operationsC$7.6M · 8%Debt repayment: C$1.9MDebt repaymentC$1.9M · 2%C$92.0M
Cash from operations
−C$7.6M
Capital expenditures
−C$17.0M
Investments (net)
+C$1.5M
Acquisitions & other
−C$65.5M
Net borrowing (repayment)
−C$1.9M
Shares issued
+C$41.2M
Currency & other
+C$317,000
Change in cash
−C$49.0M

Drawn to scale: where the cash came from and how it was used. Hover for values.

OGI operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

OGI cash flow trends, FY2016–FY2025

OrganiGram Holdings Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−C$1.8MFY2016−C$7.6MFY2025—
Capital expendituresC$4.4MFY2016C$17.0MFY2025+16.2%/yr
Free cash flow−C$6.2MFY2016−C$24.6MFY2025—
Free cash flow margin−101.0%FY2016−13.2%FY2025+87.8 pts
Operating cash flow / net income−2.09FY2016−0.57FY2018+1.52
Stock-based compensationC$442,349FY2016C$4.2MFY2025+28.5%/yr
Dividends paidC$0FY2016C$0FY2022—
Share buybacks (net)C$0FY2016C$0FY2019—
Capex / revenue72.1%FY20169.2%FY2025−62.9 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

OGI cash flow by activity

OperatingInvestingFinancingChange in cash

OGI net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

OGI cash flow statement in Canadian dollars

OrganiGram Holdings Inc. annual cash flow statement
FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating activities
Net income−C$24.8M−C$45.4M−C$229.5M−C$14.3M−C$130.7M−C$136.2M−C$9.5MC$22.1M−C$10.8MC$846,663
Depreciation & amortizationC$18.0MC$12.1MC$24.1MC$24.9MC$31.0MC$18.0MC$8.9MC$3.5MC$1.6MC$785,593
Stock-based compensationC$4.2MC$7.2MC$5.3MC$5.1MC$3.9MC$7.8MC$14.9MC$5.0MC$2.2MC$442,349
Change in working capital−C$2.1MC$15.0MC$12.5M−C$22.9MC$14.5MC$29.0M−C$57.0M−C$46.5M−C$2.8M−C$4.0M
Other non-cash items−C$2.9MC$15.1MC$152.5M−C$29.1MC$52.7MC$36.2MC$7.6MC$3.1MC$528,000C$116,788
Cash from operating activities−C$7.6MC$3.9M−C$35.1M−C$36.2M−C$28.6M−C$45.1M−C$35.1M−C$12.7M−C$9.3M−C$1.8M
Investing activities
Capital expenditures−C$17.0M−C$5.3M−C$26.9M−C$48.8M−C$12.3M−C$78.7M−C$110.3M−C$56.4M−C$31.2M−C$4.4M
Investments (net)C$1.5M−C$38.8MC$20.1MC$95.5M−C$72.5M−C$138.2M−C$46.8M−C$98.0M−C$42.6M−C$27.2M
Acquisitions & other investing−C$65.5MC$13.3MC$8.1M−C$2.7M−C$30.3MC$78.7MC$110.3MC$56.4MC$34.3MC$4.4M
Cash from investing activities−C$81.1M−C$30.8MC$1.4MC$44.0M−C$115.1M−C$138.2M−C$46.8M−C$98.0M−C$39.4M−C$27.2M
Financing activities
Dividends paid———C$0C$0C$0C$0C$0C$0C$0
Share repurchases & issuance (net)——————C$35.1MC$64.2MC$45.5MC$37.7M
Net borrowing (repayment)−C$1.9M−C$786,000−C$772,615−C$1.0M−C$116.4MC$64.0MC$47.4MC$114.8M−C$1.8MC$2.6M
Shares issuedC$41.2MC$108.6MC$0C$0C$284.9MC$100.0MC$0C$57.5MC$0C$0
Other financingC$4,000C$6,000−C$41,809C$6.3MC$6.0M−C$3.7M−C$8.2M−C$72.5M−C$2.9M−C$3.0M
Cash from financing activitiesC$39.3MC$107.8M−C$814,424C$5.3MC$174.5MC$160.4MC$74.3MC$163.9MC$40.8MC$37.3M
Summary
Net change in cash−C$49.0MC$80.8M−C$36.9MC$13.2MC$30.8M−C$23.0M−C$7.5MC$53.1M−C$7.9MC$8.4M
Cash at end of periodC$83.6MC$132.6MC$33.9MC$68.5MC$55.4MC$24.6MC$47.6MC$55.1MC$2.0MC$9.9M
Free cash flow−C$24.6M−C$1.5M−C$62.0M−C$85.0M−C$40.9M−C$123.8M−C$145.4M−C$69.1M−C$40.4M−C$6.2M
Free cash flow margin−13.2%−0.9%−41.5%−58.3%−51.6%−142.6%−180.8%−556.3%−750.5%−101.0%
Capex / revenue9.2%3.3%18.0%33.5%15.5%90.6%137.2%454.1%578.5%72.1%
Operating cash flow / net income———————−0.57—−2.09

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in Canadian dollars as reported; data from EODHD.

OGI cash generation

In fiscal 2025 (ended September 30, 2025), OrganiGram generated -C$7.6 million of cash from operations (down 296.0%) and spent C$17.0 million on capital expenditures, leaving free cash flow of -C$24.6 million, −13.2% of revenue. Cash and equivalents fell by C$49.0 million over the year.

Related: OGI income statement, OGI balance sheet. See the OGI stock overview for the latest quote and news.

OGI cash flow FAQ

What is OrganiGram's free cash flow?

OrganiGram's free cash flow was -C$24.6 million in fiscal 2025: -C$7.6 million of operating cash flow minus C$17.0 million of capital expenditures It was -C$1.5 million a year earlier..

How much cash does OrganiGram generate from operations?

OrganiGram generated -C$7.6 million of cash from operating activities in fiscal 2025.

How much does OrganiGram spend on capital expenditures?

OrganiGram spent C$17.0 million on capital expenditures in fiscal 2025, 9.2% of revenue, compared with C$5.3 million the year before.

Drug Manufacturers - Specialty & Generic: cash flow